-
-
-
-
-
-
-
Wolfe Research Starts Mirum Pharmaceuticals (MIRM) at Outperform
-
-
-
-
-
-
-
Mirum Pharmaceuticals (MIRM) PT Raised to $112 at Baird
-
-
-
-
-
-
-
Citizens Reiterates Market Outperform Rating on Mirum Pharmaceuticals (MIRM)
-
-
-
-
-
-
-
Mirum receives Health Canada approval for LIVMARLI tablet formulation
-
-
-
-
-
-
-
Mirum launches phase 2 trial for Fragile X syndrome treatment
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)
-
-
-
-
-
-
-
Mirum Pharmaceuticals, Inc. (MIRM) Tops Q3 EPS by 20c ; Offers Guidance
-
416,802 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

